TELO Stock Analysis: Buy, Sell, or Hold?
TELO - Telomir Pharmaceuticals, Inc. Common Stock
$1.31
-0.01 (-0.76%)
▼
5d:
-6.43%
30d:
+3.97%
90d:
+13.91%
HOLD
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 13, 2026
4d
Get Alerted When TELO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TELO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TELO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TELO is currently trading at $1.31, which is considered fair relative to its 30-day fair value range of $1.27 to $1.42.
Technical Outlook: Technically, TELO is in a downtrend. The price is currently testing key support at $1.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+1074.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TELO is in a downtrend. The price is currently testing key support at $1.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+1074.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.27 -
$1.42
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1074.2% below Wall St target ($15.50)
- CAUTION: Recommendation downgraded due to -6.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.27 -
$1.42
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.50
Current Trend
Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.71
Wall Street Target
$15.50
(+1074.2%)
Share & Embed Analysis
Last updated: May 08, 2026 10:28 AM ET
Data refreshes hourly during market hours. Next update: 11:28 AM
Data refreshes hourly during market hours. Next update: 11:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELO showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$100 | 69 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 67 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 55 HOLD |
|
ATYR
aTyr Pharma, Inc. |
STRONG BUY
11 analysts |
$4 | 66 BUY |
